OBJECTIVE: To prospectively evaluate the technical feasibility of percutaneous real-time contrast-enhanced ultrasound (CEUS) guided biopsy of focal hepatic lesions that are not confidently localised on B-mode US. METHODS: The study included 44 patients (mean age, 61.3 years) whose biopsy target could not be confidently localised on B-mode US performed by two independent radiologists. Biopsy was attempted under the guidance of both CEUS and B-mode US simultaneously displayed on a single monitor. Final diagnosis was established based on the pathological examination of the biopsy specimen as well as on clinical and radiological follow-up. RESULTS: The size and depth of the target lesions were 18.0 +/- 9.0 mm (mean +/- SD) and 41.8 +/- 17.2 mm respectively. Five patients with negative or indistinct CEUS findings did not undergo biopsy, while 39 patients completed the biopsy. In 38 of the 39 patients, the biopsy result was concordant with the final diagnosis. In the remaining one patient, the biopsy failed to prove metastasis. As there were six cases of technical failure, the technical success rate was 86% (38/44). The sensitivity in diagnosing malignancy was 88% (30/34). CONCLUSION: Real-time CEUS-guided biopsy is technically feasible for hepatic focal lesions that are not confidently localised on B-mode US.
OBJECTIVE: To prospectively evaluate the technical feasibility of percutaneous real-time contrast-enhanced ultrasound (CEUS) guided biopsy of focal hepatic lesions that are not confidently localised on B-mode US. METHODS: The study included 44 patients (mean age, 61.3 years) whose biopsy target could not be confidently localised on B-mode US performed by two independent radiologists. Biopsy was attempted under the guidance of both CEUS and B-mode US simultaneously displayed on a single monitor. Final diagnosis was established based on the pathological examination of the biopsy specimen as well as on clinical and radiological follow-up. RESULTS: The size and depth of the target lesions were 18.0 +/- 9.0 mm (mean +/- SD) and 41.8 +/- 17.2 mm respectively. Five patients with negative or indistinct CEUS findings did not undergo biopsy, while 39 patients completed the biopsy. In 38 of the 39 patients, the biopsy result was concordant with the final diagnosis. In the remaining one patient, the biopsy failed to prove metastasis. As there were six cases of technical failure, the technical success rate was 86% (38/44). The sensitivity in diagnosing malignancy was 88% (30/34). CONCLUSION: Real-time CEUS-guided biopsy is technically feasible for hepatic focal lesions that are not confidently localised on B-mode US.
Authors: Linda Chami; Nathalie Lassau; David Malka; Michel Ducreux; Sophie Bidault; Alain Roche; Dominique Elias Journal: AJR Am J Roentgenol Date: 2008-03 Impact factor: 3.959
Authors: Joerg Stattaus; Stefan Maderwald; Hideo A Baba; Guido Gerken; Joerg Barkhausen; Michael Forsting; Mark E Ladd Journal: Eur Radiol Date: 2008-07-19 Impact factor: 5.315
Authors: Michael R Acord; Anne Marie Cahill; Rachelle Durand; Dean Y Huang; Sphoorti Shellikeri; Seth Vatsky; Abhay Srinivasan Journal: Pediatr Radiol Date: 2021-05-12
Authors: Christoph F Dietrich; Malay Sharma; Robert N Gibson; Dagmar Schreiber-Dietrich; Christian Jenssen Journal: World J Gastroenterol Date: 2013-06-07 Impact factor: 5.742
Authors: Ernst Michael Jung; Chris Friedrich; Patrick Hoffstetter; Lena Marie Dendl; Frank Klebl; Ayman Agha; Phillipp Wiggermann; Christian Stroszcynski; Andreas Georg Schreyer Journal: PLoS One Date: 2012-03-20 Impact factor: 3.240